What does cygnus — acquisitions mean?

Captures the capital expenditure or investment outlays directed toward acquiring new businesses or assets specifically integrated into the Cygnus segment. This metric is a key indicator of the company's inorganic growth strategy and its commitment to expanding the segment's market capabilities.

Maravai LifeSciences Holdings, Inc. (MRVI) Cygnus — Acquisitions

Screener

Other segment segments

TriLink

$12.21M—

Similar metrics at other companies

HDOther — Acquisitions

$109M+419%

HPQPrinting — Acquisitions

$0-100%

CSCOAmericas — Acquisitions

$18M-18.2%

LZBRetail — Acquisitions

$14.41M+275%

LZBWholesale — Acquisitions

$0—

ABMAviation — Acquisitions

$0—

Other financials

Income statement

See full

Revenue$51.4M+8.5%

Gross profit$20.7M+166%

Operating income-$15.1M+77.2%

Net income-$12.4M+68.6%

EPS (diluted)-$0.08+70.4%

Balance sheet

See full

Cash & equivalents$70.6M-73.8%

Total debt$176.7M-52.4%

Total equity$204.6M-23.0%

Total assets$603.7M-32.7%

Cash flow

See full

Operating cash flow$4.0M+139%

CapEx$370.0K-87.1%

Free cash flow$3.6M+128%

Valuation

See full

Market cap$918.96M+210%

Enterprise value$1.03B+158%

P/S4.4×+3.1×

Profitability

See full

Gross margin34.9%+4.4pp

Operating margin-56.1%-21.3pp

Net margin-37.1%-13.6pp

FCF margin-17.2%—

Returns & leverage

See full

Return on equity-32.9%-9.4pp

Debt / equity0.9×-0.5×

Current ratio4.1×-1.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GoodwillAcquiredDuringPeriod.

The source filing: Maravai LifeSciences Holdings, Inc.’s 10-K, filed February 26, 2026.

Filed: Feb 26, 2026, 4:06 PM EST
Fiscal year: FY2025
Accession: 0001823239-26-000011

Line item	Tri Link (1)	Cygnus (2)	Total
Balance as of December 31, 2024	$39,950	$119,928	$159,878
Acquisitions	12,207	—	12,207
Impairment	(42,884)	—	(42,884)
Foreign currency translation	228	—	228
Balance as of December 31, 2025	$9,501	$119,928	$129,429

Item 8. Financial Statements and Supplementary Data

FAQ

What is Maravai LifeSciences Holdings, Inc.'s cygnus — acquisitions?: Maravai LifeSciences Holdings, Inc. (MRVI) reported cygnus — acquisitions of $0 in Q4 2025.
What does cygnus — acquisitions mean?: Captures the capital expenditure or investment outlays directed toward acquiring new businesses or assets specifically integrated into the Cygnus segment. This metric is a key indicator of the company's inorganic growth strategy and its commitment to expanding the segment's market capabilities.